Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, the growing measles outbreak in Texas, and more. To get it in your inbox, ...

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- New York Blood Center Enterprises (NYBCe) and Human Life CORD Japan Inc. (Human Life CORD) have signed a Letter of Intent to expand their manufacturing ...

Calgary, Alberta--(Newsfile Corp. - February 19, 2025) - Hemostemix Inc. (HEM:CA) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce a strategic breakthrough that ...

Discover how work cells streamline manufacturing by enhancing efficiency, reducing costs, and minimizing waste, with real-world examples of successful implementation.

A pioneer in Taiwan’s advanced manufacturing cell technologies, YJ Biotechnology has quickly established itself as one of the country’s leading names in the development of regenerative medicine.

The New York Stem Cell Foundation, a $23-million-a-year biomedical nonprofit, was acquired by the Jackson Laboratory as part of a move to expand automation in life sciences research. The acquisition, ...

The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.

Cell and Gene Therapy Catapult’s Stevenage Manufacturing Innovation Centre Photo credit: Cell and Gene Therapy Catapult The first facility, housed within the Cell and Gene Therapy Catapult’s (CGT ...